NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing

Mark Duggan, Fiona Scott Morton

NBER Working Paper No. 10930
Issued in November 2004
NBER Program(s):   HC   IO

The federal-state Medicaid program insures 43 million people for virtually all of the prescription drugs approved by the FDA. To determine the price that it will pay for a drug treatment, the government uses the average price in the private sector for that same drug. Assuming that Medicaid recipients are unresponsive to price because of the program's zero co-pay, this rule will increase prices for non-Medicaid consumers. Using drug utilization and expenditure data for the top 200 drugs in 1997 and in 2002, we investigate the relationship between the Medicaid market share (MMS) and the average price of a prescription. Our findings suggest that the Medicaid rules substantially increase equilibrium prices for non-Medicaid consumers. Specifically, a ten percentage-point increase in the MMS is associated with a ten percent increase in the average price of a prescription. This result is robust to the inclusion of controls for a drug's therapeutic class, the existence of generic competition, the number of brand competitors, and the years since the drug entered the market. We also demonstrate that the Medicaid rules increase a firm's incentive to introduce new versions of a drug at higher prices and find empirical evidence in support of this for drugs that do not face generic competition. Taken together, our findings suggest that government procurement can have an important effect on equilibrium prices in the private sector.

download in pdf format
   (329 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (329 K) or via email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Published: Duggan, Mark and Fiona M. Scott Morton. "The Distortionary Effects Of Government Procurement: Evidence From Medicaid Prescription Drug Purchasing," Quarterly Journal of Economics, 2006, v121(1,Feb), 1-30.

Users who downloaded this paper also downloaded these:
Chen and Whalley w17365 The WTO Government Procurement Agreement and Its Impacts on Trade
Duggan and Scott Morton w13917 The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
Fong and Schwarz w14718 Towards an Efficient Mechanism for Prescription Drug Procurement
Bajari, McMillan, and Tadelis w9757 Auctions Versus Negotiations in Procurement: An Empirical Analysis
Frank and Salkever w3803 Pricing, Patent Loss and the Market For Pharmaceuticals
 
Publications
Activities
Meetings
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us